Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
309
-
Total 13F shares, excl. options
-
117M
-
Shares change
-
-775K
-
Total reported value, excl. options
-
$6.33B
-
Value change
-
-$39.7M
-
Put/Call ratio
-
1.62
-
Number of buys
-
117
-
Number of sells
-
-148
-
Price
-
$54.06
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q4 2018
379 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q4 2018.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 309 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 117M shares
of 159M outstanding shares and own 73.86% of the company stock.
Largest 10 shareholders include FMR LLC (20.5M shares), Vanguard Group Inc (11.8M shares), Clearbridge Investments, LLC (10.4M shares), BAILLIE GIFFORD & CO (8.75M shares), BB BIOTECH AG (8.74M shares), BlackRock Inc. (7.68M shares), WELLINGTON MANAGEMENT GROUP LLP (7.63M shares), WADDELL & REED FINANCIAL INC (3.5M shares), STATE STREET CORP (2.54M shares), and FIRST TRUST ADVISORS LP (2.22M shares).
This table shows the top 309 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.